Lv3
310 积分 2022-10-10 加入
Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling
27天前
已完结
A unified strategy in selection of the best allometric scaling methods to predict human clearance based on drug disposition pathway
27天前
已完结
Biotransformation and disposition characteristics of HSK7653, a novel long‐acting dipeptidyl peptidase‐4 inhibitor for the treatment of type 2 diabetes
30天前
已完结
Dose decision of HSK7653 oral immediate release tablets in specific populations clinical trials based on mechanistic physiologically-based pharmacokinetic model
30天前
已完结
Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers
30天前
已完结
Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation
4个月前
已完结
Pharmacology of PROTAC Degrader Molecules
5个月前
已完结
Developing Pharmacokinetic/Pharmacodynamic Relationships With PROTACs
5个月前
已完结
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
5个月前
已完结
Population Pharmacokinetics of Talazoparib in Patients With Advanced Cancer
5个月前
已完结
皖公网安备34019202002308
